As of May 27
| +0.03 / +0.58%|
The 8 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 20.00 and a low estimate of 3.00. The median estimate represents a +131.21% increase from the last price of 5.19.
The current consensus among 9 polled investment analysts is to Buy stock in Infinity Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.